Journals / Turkish Journal of Clinics and Laboratory / 2022 / Cilt: 13 - Sayı: 2

Investigation of the frequency of helicobacter pylori, chronic gastritis and gastric cancer observed in the stomach in the local population

Lokal populasyonda midede izlenen helicobakter pylori, kronik gastrit ve mide kanseri sıklığının incelenmesi

Pages
275–279
Publication Date
2022-11-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is thought that the changes in its prevalence may be related to environmental factors, nutrition, hygiene and development level.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, it is aimed to investigate the frequency of Helicobacter pylori, chronic gastritis and gastric cancer in the population with dyspeptic complaints.
📊
Key Findings & Data:Material and Methods: Between January 2020 and November 2021, the pathology results of 2082 patients' endoscopic gastric mucosa specimens, based on the updated Sydney System, were analyzed retrospectively.
💡
Conclusion & Impact:It is thought that the changes in its prevalence may be related to environmental factors, nutrition, hygiene and development level.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:h.pylori · mide kanseri · endoskopi

Abstract

Aim: In this study, it is aimed to investigate the frequency of Helicobacter pylori, chronic gastritis and gastric cancer in the population with dyspeptic complaints. Material and Methods: Between January 2020 and November 2021, the pathology results of 2082 patients' endoscopic gastric mucosa specimens, based on the updated Sydney System, were analyzed retrospectively. Results: When evaluated for H. pylori, it was reported as H. pylori + in 733 (37.4%) of 1961 patients and 30.2% of all patients. There was no significant gender difference in the prevalence of H. Pylori. Precancerous and cancerous lesions were detected in the remaining 121 patients, and adenocarcinoma was found in 94 of these lesions. Conclusion: The prevalence of H.pylori was 30.2%. The prevalence of gastric cancer was found to be 4.5%. It is thought that the changes in its prevalence may be related to environmental factors, nutrition, hygiene and development level.

Özet

Amaç: Bu çalışmada dispeptik şikayetleri olan toplumda Helicobakter pylori, kronik gastrit ve mide kanseri sıklığının araştırılması amaçlanmaktadır. Gereç ve Yöntemler: Ocak 2020 ve Kasım 2021 tarihleri arasında, 2082 hastanın endoskopik gastrik mukoza örneklerinin, güncelleştirilmiş Sydney Sistemi esas alınarak düzenlenmiş patoloji sonuçları, retrospektif analiz edildi. Bulgular: H.pylori açısından değerlendirildiğinde 1961 hastanın 733’ünde (%37,4), tüm hastaların %30,2’sinde H.pylori + olarak raporlandı. H. Pylori prevelansında cinsiyet açısından anlamlı fark saptanmadı. Kalan 121 hastada prekanseröz ve kanseröz lezyonlar ve bu lezyonların 94’ünde adenokarsinom saptandı. Sonuç: H.pylori prevelansı %30,2 olarak izlenmiştir. Mide kanser prevelansı %4,5 olarak saptanmıştır. Prevelansındaki değişiklikler çevresel faktörler, beslenme, hijyen ve gelişmişlik düzeyi ile ilgili olabileceği düşünülmektedir.

🔖

Cite This Article

DURAK, D., ALKURT, E. G., TURHAN, V. B., KÖSEOĞLU, H. (2022). Investigation of the frequency of helicobacter pylori, chronic gastritis and gastric cancer observed in the stomach in the local population. Turkish Journal of Clinics and Laboratory, Cilt: 13 - Sayı: 2, 275–279. https://ajindex.com/articles/602802

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Lawson AJ. Helicobacter. In: Jorgensen JH, Landry ML, Warnock DW (Eds.) Manual of Clinical Microbiology. Washington DC: ASM Press, 2011; 900-15
  2. Fock KM, Graham DY, Malfertheiner P. Helicobacter pylori research: historical insights and future directions. Nat Rev Gastroenterol Hepatol 2013; 10: 495-500 3. Schirer WH, Schoengold RJ, Baker JT, et al. Development of FlexSure HP-an immunochromatographic method to detect antibodies against Helicobacter pylori. Clin Chem 1998; 44: 293-8
  3. IARC Helicobacter pylori Working Group. Helicobacter pylori eradication on as a strategy for preventing gastric cancer. Lyon, France: International Agency for Research on Cancer (IARC Working Group Reports No:8); 2014
  4. Özkan TB. Çocuklarda Helicobacter pylori enfeksiyonunda seroloji, tanı ve tedavi. Uludağ Üni Tıp Fak Derg 2007; 33: 81-5
  5. Megraud F, Lehours P. Helicobacter pylori detection and antibiotic susceptibility testing. Clin Microbiol Rev. 2007; 20: 280-322
  6. Price AB, Misiewicz JJ. Sydney classification for gastritis. Lancet 1991; 337: 174
  7. Gulsen MT, Koruk I, Dogan M, Beyazit Y. Diagnostic accuracy of cascade stomach by upper gastrointestinal endoscopy in patients with obscure symptoms: a multi-center prospective trial. Clin Res Hepatol Gastroenterol. 2011; 35: 489-93
  8. McNulty C.A, Lehours P, Megraud F. Diagnosis of Helicobacter 25 pylori Infection. Helicobacter. 2011; 16: 10-8
  9. Erbey F, Acar MN, Balahur H, Güven A. Van Gölü Havzasında 1-18 Yaş Grubu Çocuklarda Helicobacter pylori sıklığı. Çocuk Enf. Derg. 2010; 4: 93-5
  10. Şimşek İ, Binicier ÖB. Helicobacter pylori. İç Hastalıkları Dergisi 2011; 18: 13-26
  11. Konakcı N, Gülten M, İbanoğlu MS, et al. Kronik aktif gastritli olgularda Helicobacter pylori sıklığı. Uludağ Üniversitesi Tıp Fakültesi Dergisi 2010; 36: 7-10
  12. Kesli R, Göktürk H.S, Erbayrak M, et al. Comparison of the diagnostic values of the 3 different stool antigen tests fort he noninvasive diagnosis of Helicobacter pylori infection. J Investig Med. 2010; 58: 982-6
  13. The Eurogast Study Group. Epidemioloji of and risk faktor for Helicobacter pylori infection among 3194 asemptomatic subject in populations. GUT 1193; 34: 1672-6 15. Joos A, Nemzeth A, Zsolnay G, et al. Gastric biopsies and Helicobacter pylori. ORV Hetil 1995; 136: 1975-82
  14. Açık Y, Gülbayrak C, Dönder E, Yalnız M. Fırat Tıp Merkezine dispeptik yakınmalarla başvuran hastalarda helicobacter pylori sıklığı ve etkileyen faktörler O.M.Ü Tıp Dergisi 2003; 20(1): 8